CN111564195A - System and method for evaluating risk of multiple medication of old patients - Google Patents
System and method for evaluating risk of multiple medication of old patients Download PDFInfo
- Publication number
- CN111564195A CN111564195A CN202010364749.XA CN202010364749A CN111564195A CN 111564195 A CN111564195 A CN 111564195A CN 202010364749 A CN202010364749 A CN 202010364749A CN 111564195 A CN111564195 A CN 111564195A
- Authority
- CN
- China
- Prior art keywords
- information
- risk
- medication
- evaluated
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 335
- 229940079593 drug Drugs 0.000 title claims abstract description 254
- 238000000034 method Methods 0.000 title claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 76
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 76
- 230000002452 interceptive effect Effects 0.000 claims abstract description 55
- 238000011156 evaluation Methods 0.000 claims abstract description 29
- 238000005065 mining Methods 0.000 claims abstract description 13
- 238000007405 data analysis Methods 0.000 claims abstract description 7
- 208000011580 syndromic disease Diseases 0.000 claims description 29
- 230000003993 interaction Effects 0.000 claims description 13
- 238000012502 risk assessment Methods 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 206010031127 Orthostatic hypotension Diseases 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 230000003444 anaesthetic effect Effects 0.000 description 4
- 210000000748 cardiovascular system Anatomy 0.000 description 4
- 238000001647 drug administration Methods 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229960002896 clonidine Drugs 0.000 description 3
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 3
- 229960003529 diazepam Drugs 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 2
- 229960001076 chlorpromazine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000001089 Multiple system atrophy Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229960004372 aripiprazole Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 229940000032 cardiovascular system drug Drugs 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 229940124278 endocrine system drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229940000041 nervous system drug Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 229960004431 quetiapine Drugs 0.000 description 1
- URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 description 1
- 229940000044 respiratory system drug Drugs 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses a system and a method for evaluating the risk of multiple medication of an old patient, belonging to the technical field of internet medical treatment and comprising a multiple medication risk database, a multiple medication evaluation intelligent system and an interactive terminal; the multi-medication risk database is used for storing multi-medication risk data according to the medicine and disease information; the multi-use evaluation intelligent system is used for carrying out data matching and mining on the information to be evaluated from the interactive terminal, obtaining a data result corresponding to the information to be evaluated, and recording the use condition of a user at the interactive terminal for subsequent data analysis; and the interactive terminal is used for providing an interactive interface for a user, receiving and uploading information to be evaluated input by the user, receiving a data result corresponding to the information to be evaluated and displaying the data result on the corresponding interface. The invention can help medical staff to quickly inquire the information of multiple medication of the old patient, select more reasonable medicines for the old patient and ensure the medication safety of the old patient.
Description
Technical Field
The invention relates to the technical field of internet medical treatment, in particular to a system and a method for evaluating the risk of multiple medication of an old patient.
Background
With the accelerated entering of China into the aging society, common diseases and senile syndromes generally exist, and the superposition of the medication of the common diseases in a specialized diagnosis mode makes the evaluation and intervention of clinicians on multiple medication (more than or equal to five) difficult. The occurrence ratio of multiple medicines in the elderly patients with the common diseases is extremely high, which can cause the interaction between the adverse medicines and the increase of the adverse reaction of the medicines and induce the prescription waterfall, and the risk of adverse events of the medicines and the diseases is increased, thereby seriously affecting the life quality of the elderly patients and harming the health. How to effectively avoid the above situations is a problem to be solved urgently at present.
Although multidisciplinary comprehensive outpatient and clinical pharmacist consultation outpatient services are developed in a small number of large-scale comprehensive hospitals, most elderly patients with comorbidities still cannot obtain normal, effective and timely medication consultation, the potential risk of inappropriate medication in a multi-medication state caused by knowledge limitation of individual doctors is still high, the reasonable medication of the elderly patients is a great problem which puzzles clinicians and supervision departments, and a certain technology is not available for carrying out quick and comprehensive intelligent reasonable medication evaluation on the comorbidities of the elderly patients, so that the diagnosis and treatment efficiency is improved. Therefore, a system and a method for evaluating the risk of multiple drug administration of an elderly patient are provided.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: how to solve the unreasonable problem of old patient's multiple medicine use provides a old patient's multiple medicine use risk assessment system.
The invention solves the technical problems through the following technical scheme, and the system comprises a multiple medication risk database, a multiple medication evaluation intelligent system and an interactive terminal;
the multi-medication risk database is used for storing multi-medication risk data according to the medicine and disease information;
the multi-use evaluation intelligent system is used for carrying out data matching and mining on information to be evaluated from the interactive terminal, obtaining a data result corresponding to the information to be evaluated, and recording the use information of a user at the interactive terminal for subsequent data analysis;
the interactive terminal is used for providing an interactive interface for a user, receiving and uploading information to be evaluated input by the user, receiving a data result corresponding to the information to be evaluated and displaying the data result on a corresponding interface;
and the interactive terminal and the multiple medication risk database are in communication connection with the multiple medication evaluation intelligent system.
Furthermore, the intelligent system for evaluating the multiple medications comprises a usage information recording module and an information matching and intelligent recommending module; the using information recording module is used for recording the using information of the user at the interactive terminal for subsequent data analysis; the information matching and intelligent recommendation module is used for performing data matching and mining on information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database and obtaining a data result corresponding to the information to be evaluated;
furthermore, the interactive terminal comprises an information receiving and uploading module and a result display module; the information receiving and uploading module is used for receiving and uploading information to be evaluated, which is input by a user at the interactive terminal; the result display module; and the data processing module is used for returning the data result corresponding to the information to be evaluated to the interactive terminal for displaying.
Furthermore, the system for evaluating the risk of the multiple medication of the old patients further comprises a multiple medication risk database establishing module, which is used for establishing the multiple medication risk database according to the medicine and disease information.
Furthermore, the medicine and disease information includes medicine name, disease name, clinical index early warning value, and medicine and disease interaction information.
Still further, the drug-disease interaction information includes disease-drug risk, potentially inappropriate administration for geriatric syndrome, potentially inappropriate administration for the elderly, perioperative administration risk, pre-alarm value risk drugs;
wherein the disease-drug risk information is medication risk points and use suggestions for using a certain drug in a known geriatric disease state; potentially inappropriate medication for geriatric syndrome information is inappropriate medication in the context of known geriatric syndrome; the potential improper medication risk information of the old people is medication risk point/use suggestions corresponding to some medicines which may not be suitable for the old people, class A and B warning medicine classification and risk intensity of the medicines; the perioperative medication risk information is the potential risk and use suggestion corresponding to the improper medication of the elderly patients in the period from the determination of the start of the operation treatment to the end of the operation treatment; the early warning value risk medicine information is risk medicine of the old in a certain physiological index range.
Further, the information to be evaluated comprises drug-disease names, senile syndrome names, potentially inappropriately used drug names of the elderly, perioperative risk drug names and clinical index early warning values.
Furthermore, the information to be evaluated is a medicine-disease name, the information matching and intelligent recommending module searches the disease-medicine risk information corresponding to the medicine-disease name in the multi-medication risk database, and the disease-medicine risk information is used as a multi-medication risk evaluation result of the elderly patients.
Furthermore, the information to be evaluated is the name of the senile syndrome, the information matching and intelligent recommending module searches the multiple medication risk database for the potentially inappropriate medication information of the senile syndrome corresponding to the name of the senile syndrome, and the potentially inappropriate medication information of the senile syndrome is used as the multiple medication risk evaluation result of the elderly patients.
Furthermore, the information to be evaluated is the names of the potentially improper medication drugs of the old people, the information matching and intelligent recommending module searches the multiple medication risk database for the potentially improper medication risk information of the old people corresponding to the names of the potentially improper medication drugs of the old people, and the potentially improper medication risk information of the old people is used as the multiple medication risk evaluation result of the old patients.
Furthermore, the information to be evaluated is a perioperative period risk drug name, the information matching and intelligent recommending module searches the perioperative period drug risk information corresponding to the perioperative period risk drug name in the multi-drug risk database, and the perioperative period drug risk information is used as a multi-drug risk evaluation result of the elderly patient.
Furthermore, the information to be evaluated is a clinical index early warning value, the information matching and intelligent recommending module searches early warning value risk drug information corresponding to the clinical index early warning value in the multi-medication risk database, and the early warning value risk drug information is used as an old patient multi-medication risk evaluation result.
The invention also provides a multi-medication risk assessment method for the old patients, which utilizes the multi-medication risk assessment system for the old patients to assess the multi-medication risk of the old patients and comprises the following steps:
s101: establishing a multi-medication risk database
Establishing and storing a multiple medication risk database according to the medicine and disease information;
s102: receiving and uploading information
Receiving and uploading information to be evaluated input by a user at an interactive terminal;
s103: information matching and intelligent recommendation
Performing data matching and mining on information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database, and obtaining a data result corresponding to the information to be evaluated;
s104: show the results
Returning a data result corresponding to the information to be evaluated to the interactive terminal for displaying;
s105: recording usage information
And recording the use information of the user at the interactive terminal for subsequent analysis.
Compared with the prior art, the invention has the following advantages: according to the system and the method for evaluating the risk of multiple medication of the old patient, the corresponding old patient risk database of multiple medication is established, the information to be evaluated of the interactive terminal is received, the result related to the information to be evaluated is inquired, the result is finally displayed on the interactive terminal and the inquiry information of the user is recorded, medical staff can be helped to quickly inquire the information of multiple medication of the old patient, more reasonable medicines are selected for the old patient, the medication safety of the old patient is guaranteed, and the system and the method are worthy of being popularized and used.
Drawings
FIG. 1 is a schematic flow chart of a method for evaluating the risk of multiple drug administrations in an elderly patient according to an embodiment of the present invention;
FIG. 2 is a schematic diagram of interaction between a system for evaluating the risk of multi-medication for middle-aged and elderly patients and a user according to a second embodiment of the present invention
FIG. 3 is a block diagram of a system for evaluating the risk of multiple medications taken by middle-aged and elderly patients according to a second embodiment of the present invention
FIG. 4 is a flowchart illustrating a method for evaluating the risk of multiple medications for middle-aged and elderly patients according to a second embodiment of the present invention.
Detailed Description
The following examples are given for the detailed implementation and specific operation of the present invention, but the scope of the present invention is not limited to the following examples.
Example one
The embodiment provides a technical scheme: a risk assessment system for multiple medication of an old patient comprises a multiple medication risk database, a multiple medication assessment intelligent system and an interactive terminal;
the multi-medication risk database is used for storing multi-medication risk data according to the medicine and disease information;
the multi-use evaluation intelligent system is used for carrying out data matching and mining on information to be evaluated from the interactive terminal, obtaining a data result corresponding to the information to be evaluated, and recording the use condition of a user at the interactive terminal for subsequent data analysis;
the interactive terminal is used for providing an interactive interface for a user, receiving and uploading information to be evaluated input by the user, receiving a data result corresponding to the information to be evaluated and displaying the data result on a corresponding interface;
and the interactive terminal and the multiple medication risk database are in communication connection with the multiple medication evaluation intelligent system.
The multi-use evaluation intelligent system comprises a use information recording module and an information matching and intelligent recommending module; the using information recording module is used for recording the using condition of the user at the interactive terminal for subsequent data analysis; the information matching and intelligent recommendation module is used for performing data matching and mining on information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database and obtaining a data result corresponding to the information to be evaluated;
the interactive terminal comprises an information receiving and uploading module and a result display module; the information receiving and uploading module is used for receiving and uploading information to be evaluated, which is input by a user at the interactive terminal; the result display module; and the data processing module is used for returning the data result corresponding to the information to be evaluated to the interactive terminal for displaying.
The system for evaluating the risk of the multiple medication of the old patients further comprises a multiple medication risk database establishing module which is used for establishing the multiple medication risk database according to the medicine and disease information.
The medicine and disease information comprises medicine names, disease names, clinical index early warning values and medicine and disease interaction information.
The drug disease interaction information includes disease-drug risk, potentially inappropriate administration for geriatric syndrome, potentially inappropriate administration risk for the elderly, perioperative administration risk, pre-alarm value risk drugs;
wherein the disease-drug risk information is medication risk points and use suggestions for using a certain drug in a known geriatric disease state; potentially inappropriate medication for geriatric syndrome information is inappropriate medication in the context of known geriatric syndrome; the potential improper medication risk information of the old people is medication risk point/use suggestions corresponding to some medicines which may not be suitable for the old people, and the A, B level is adopted to warn the classification of the medicines and the risk intensity of the medicines; the perioperative medication risk information is the potential risk and use suggestion corresponding to the improper medication of the elderly patients in the period from the determination of the start of the operation treatment to the end of the operation treatment; the early warning value risk medicine information is risk medicine of the old in a certain physiological index range.
The information to be evaluated comprises medicine-disease names, senile syndrome names, potentially improper medication names of the elderly, perioperative risk medicine names and clinical index early warning values.
The information to be evaluated is a medicine-disease name, the information matching and intelligent recommending module searches the disease-medicine risk information corresponding to the medicine-disease name in the multi-medication risk database, and the disease-medicine risk information is used as a multi-medication risk evaluation result of the old patient.
The information to be evaluated is the name of the senile syndrome, the information matching and intelligent recommending module searches the potential improper medication information of the senile syndrome corresponding to the name of the senile syndrome in the multi-medication risk database, and the potential improper medication information of the senile syndrome is used as a multi-medication risk evaluation result of the elderly patients.
The information to be evaluated is the names of the potentially improper medication drugs of the old people, the information matching and intelligent recommending module searches the multiple medication risk database for the potentially improper medication risk information of the old people corresponding to the names of the potentially improper medication drugs of the old people, and the potentially improper medication risk information of the old people is used as the multiple medication risk evaluation result of the old patients.
The information to be evaluated is perioperative period risk medicine names, the information matching and intelligent recommending module searches the perioperative period medicine risk information corresponding to the perioperative period risk medicine names in the multi-medicine risk database, and the perioperative period medicine risk information is used as a multi-medicine risk evaluation result of the elderly patients.
The information to be evaluated is a clinical index early warning value, the information matching and intelligent recommending module searches early warning value risk medicine information corresponding to the clinical index early warning value in the multi-medication risk database, and the early warning value risk medicine information is used as a multi-medication risk evaluation result of the old patients.
As shown in fig. 1, the present embodiment further provides a method for evaluating the risk of multiple medication for an elderly patient, which utilizes the system for evaluating the risk of multiple medication for an elderly patient to evaluate the risk of multiple medication for an elderly patient, and includes the following steps:
s101: establishing a multi-medication risk database
Establishing and storing a multiple medication risk database according to the medicine and disease information;
s102: receiving and uploading information
Receiving and uploading information to be evaluated input by a user at an interactive terminal;
s103: information matching and intelligent recommendation
Performing data matching and mining on information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database, and obtaining a data result corresponding to the information to be evaluated;
s104: show the results
Returning a data result corresponding to the information to be evaluated to the interactive terminal for displaying;
s105: recording usage information
And recording the use condition of the user at the interactive terminal for subsequent analysis.
Example two
As shown in fig. 2, in this embodiment, for the process of intelligent interaction between the multiple medication risk assessment system for the elderly patients and the user, the WeChat terminal (interactive terminal) receives the search information from the user, and finally feeds back the result to the user to achieve data intercommunication and intelligent interaction by combining the multiple medication risk assessment intelligent system for the elderly patients with the multiple medication risk database. The wechat terminal refers to a wechat applet.
As shown in fig. 3, the present embodiment provides a system 100 for evaluating the risk of multiple drug administration for an elderly patient, which mainly includes:
the multi-medication risk database establishing module 101 is used for establishing and storing a multi-medication risk database according to medicine and disease information, wherein the medicine and disease information comprises medicine names, disease names, clinical index early warning values and medicine and disease interaction information;
the drug disease interaction information comprises disease-drug risk, potential improper medication of senile syndrome, potential improper medication risk of old people, medication risk in perioperative period and early warning value risk drugs, wherein the disease-drug risk refers to adverse effects caused by using a certain drug in known senile disease states and comprises medication risk points and use suggestions of the drug; potentially inappropriate administration of geriatric syndrome refers to inappropriate administration given the known circumstances of geriatric syndrome; the potential improper medication risk of the old refers to medication risk points/use suggestions corresponding to some medicines which may not be suitable for the old, class a and B warning medicine classification and risk intensity of the medicines; the perioperative medication risk indicator is used for determining the potential risk and use suggestion corresponding to improper medication of an old patient in the period from the beginning of the determined operation treatment to the end of the operation treatment; the early warning value risk medicine refers to the risk medicine of the old in a certain physiological index range.
The information receiving and uploading module 102 is configured to receive information to be evaluated input by a user at the wechat terminal and upload the information to be evaluated input by the user at the wechat terminal;
the information to be evaluated comprises medicine-disease names, senile syndrome names, names of potentially improper medicines for the elderly, names of perioperative risk medicines and clinical index early warning values.
The input form of the information to be evaluated is two, the full name of the medicine name or the disease name can be selected according to the automatic prompt after a single character is input, or the information to be evaluated which needs to be input can be selected in a pull-down list in a sliding mode.
The information matching and intelligent recommendation module 103 is used for performing data matching and mining on information to be evaluated from the WeChat terminal according to the medicine and disease information in the multi-medication risk database, and obtaining a data result corresponding to the information to be evaluated;
specifically, the information to be evaluated sent by the information receiving and uploading module 102 may include the following five conditions according to the content input by the user:
if the input information to be evaluated is a medicine-disease name, the information matching and intelligent recommendation module 103 searches a disease-medicine risk corresponding to the medicine-disease name in the multi-medication risk database, and takes the disease-medicine risk as a multi-medication risk evaluation result of the elderly patient. Before inputting the disease name, the system to which the disease to be queried belongs, including nervous system, cardiovascular system, urinary system, digestive system, respiratory system, endocrine system, and others, can be judged according to professional knowledge for the convenience of doctors. The user may select a system and then enter the drug-disease name. For example, postural hypotension is known to be a cardiovascular disease, the information to be evaluated sent by the information receiving and uploading module 102 is chlorpromazine postural hypotension, which is found in the multi-medication risk database, adverse effects caused by chlorpromazine use in the postural hypotension state are known, including increased postural hypotension and fall risk, and the use advice is provided by replacing a potent antipsychotic such as haloperidol and continuously monitoring the blood pressure.
If the input information to be evaluated is the name of the senile syndrome, the information matching and intelligent recommending module 103 searches the multiple medication risk database for the potential improper medication of the senile syndrome corresponding to the name of the senile syndrome, and takes the potential improper medication of the senile syndrome as the multiple medication risk evaluation result of the elderly patients. For example, the information to be evaluated sent by the information receiving and uploading module 102 is dementia, and the information is found in the multi-medication risk database, and the potential risk drugs of the known senile dementia patients include benzodiazepines, anticholinergic drugs, aripiprazole, risperidone, and quetiapine. Namely, the medicines should be used with caution for senile patients with dementia.
If the input information to be evaluated is the name of the medicine of the old person with potential improper medication, the information matching and intelligent recommending module 103 searches the multiple medication risk database for the risk of the old person with potential improper medication corresponding to the medicine name, and takes the risk of the old person with potential improper medication as the multiple medication risk evaluation result of the old patient. Before inputting the name of the medicine, the acting system of the medicine to be inquired can be judged according to professional knowledge for doctors to use conveniently, and comprises nervous system medicine, mental medicine, antipyretic, analgesic, anti-inflammatory and anti-rheumatism medicine, cardiovascular system medicine, antiallergic medicine, endocrine system medicine, blood system medicine, urinary system medicine, respiratory system medicine, anti-infective medicine, digestive system medicine, anesthetic and anesthetic auxiliary medicine and skeletal muscle relaxant. The user may select a subdivision system and then enter the drug name. For example, it is known that clonidine is taken by a cardiovascular system, the information to be evaluated, which is sent by the information receiving and uploading module 102 and belongs to the cardiovascular system, is clonidine, which is found in the multiple medication risk database, and an elderly patient has three medication risk points when using clonidine, including increasing the risk of orthostatic hypotension, increasing the risk of bradycardia, and increasing the risk of syncope, and the risk intensity of this medication is high.
If the input information to be evaluated is the perioperative period risk drug name, the information matching and intelligent recommendation module 103 searches the perioperative period drug risk corresponding to the perioperative period risk drug name in the multi-drug risk database, and takes the perioperative period drug risk as the multi-drug risk evaluation result of the elderly patient. Before inputting the name of the drug, the acting system of the drug to be inquired can be judged according to professional knowledge for the convenience of doctors, and comprises nervous system drug, anesthetic or anesthetic auxiliary drug, psychotropic drug, cardiovascular system drug, respiratory system drug, digestive system drug, urinary system drug, blood system drug, endocrine system drug, anti-infective drug, antipyretic drug, analgesic drug, anti-inflammatory drug, anti-rheumatism drug, anti-allergy drug and other drugs. The user may select a subdivision system and then enter the drug name. For example, it is known that diazepam belongs to a nervous system medication, the information to be evaluated, which is sent by the information receiving and uploading module 102 and belongs to the nervous system medication, is diazepam, which is found in the multi-medication risk database, and elderly patients who use diazepam during perioperative period have increased delirium, fall, risks of cognitive impairment and risks of hypotension, and the provided use suggestions are perioperative use and blood pressure monitoring.
If the input information to be evaluated is the clinical index early warning value, the information matching and intelligent recommendation module 103 searches an early warning value risk drug corresponding to the clinical index early warning value in the multi-medication risk database, and takes the early warning value risk drug as the multi-medication risk evaluation result of the elderly patients. For example, the information to be evaluated sent by the information receiving and uploading module 102 is blood ph > 7.45, which is found in the multi-medication risk database, and the risk drugs of the elderly patient in the clinical index early warning value range are sodium bicarbonate, furosemide and hydrochlorothiazide, which should be used carefully.
The result display module 104 is configured to return a data result corresponding to the information to be evaluated to the WeChat terminal for display;
specifically, the information matching and intelligent recommendation module 103 performs data matching and mining on the information to be evaluated from the wechat terminal according to the medicine and disease information in the multiple medication risk database. Depending on the information to be evaluated, the result presentation may be a different combination between a list of risky drugs, a point of risk/use recommendation for drug use, a category of alert drugs, a drug risk intensity.
And the use information recording module 105 is configured to record the use condition of the user at the WeChat terminal for subsequent analysis.
The use case comprises real-time access data and access data statistics of the small program, such as data of the source, the scale, the frequency, the duration and the like of the small program user access.
As shown in fig. 4, the present embodiment provides a method for evaluating the risk of multiple drug administrations to an elderly patient, which includes the following steps:
step S101: multiple medication risk database establishment procedure
Establishing and storing a multi-medication risk database according to medicine and disease information, wherein the medicine and disease information comprises medicine names, disease names, clinical index early warning values and medicine and disease interaction information; specifically, the step S101 may be executed by the multiple drug risk database building module 101, and specific description about the step S101 may refer to the description of the multiple drug risk database building module 101.
Step S102: information receiving and uploading step
Receiving and uploading information to be evaluated input by a user at a WeChat terminal; specifically, the step S102 can be executed by the information receiving and uploading module 102, and the detailed description of the step S102 can refer to the description of the information receiving and uploading module 102.
Step S103: information matching and intelligent recommendation steps
Carrying out data matching and mining on information to be evaluated from the WeChat terminal according to medicine and disease information in the multi-use risk database, and obtaining a data result corresponding to the information to be evaluated; specifically, the step S103 can be executed by the information matching and intelligent recommendation module 103, and the detailed description of the step S103 can be referred to the description of the information matching and intelligent recommendation module 103.
Step S104: step of displaying results
Returning a data result corresponding to the information to be evaluated to the WeChat terminal for displaying; specifically, the step S104 can be executed by the result displaying module 104, and the detailed description about the step S104 can refer to the description of the result displaying module 104.
Step S105: recording step of usage information
And recording the use condition of the user at the WeChat terminal for subsequent analysis. Specifically, the step S105 may be executed by the usage information recording module 105, and specific description about the step S105 may refer to the description of the usage information recording module 105 described above.
In summary, the old patient multi-medication risk assessment systems and methods of the two embodiments receive information to be assessed of the interactive terminal, query results related to the information to be assessed, and finally display the results on the interactive terminal and record query information of the user by establishing a corresponding old patient multi-medication risk database, so that medical staff can be helped to quickly query the old patient multi-medication information, more reasonable medicines can be selected for the old patient, medication safety of the old patient is guaranteed, and the old patient multi-medication risk assessment systems and methods are worthy of being popularized and used.
Furthermore, the terms "first", "second" and "first" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one such feature. In the description of the present invention, "a plurality" means at least two, e.g., two, three, etc., unless specifically limited otherwise.
In the description herein, references to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above are not necessarily intended to refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, various embodiments or examples and features of different embodiments or examples described in this specification can be combined and combined by one skilled in the art without contradiction.
Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made to the above embodiments by those of ordinary skill in the art within the scope of the present invention.
Claims (8)
1. The utility model provides an old patient's multiple drug use risk assessment system which characterized in that: the system comprises a multi-medication risk database, a multi-medication evaluation intelligent system and an interactive terminal;
the multi-medication risk database is used for storing multi-medication risk data according to the medicine and disease information;
the multi-use evaluation intelligent system is used for carrying out data matching and mining on information to be evaluated from the interactive terminal, obtaining a data result corresponding to the information to be evaluated, and recording the use information of a user at the interactive terminal for subsequent data analysis;
the interactive terminal is used for providing an interactive interface for a user, receiving and uploading information to be evaluated input by the user, receiving and displaying a data result corresponding to the information to be evaluated;
and the interactive terminal and the multiple medication risk database are in communication connection with the multiple medication evaluation intelligent system.
2. The system of claim 1, wherein the system comprises: the multi-use evaluation intelligent system comprises a use information recording module and an information matching and intelligent recommending module; the using information recording module is used for recording the using information of the user at the interactive terminal for subsequent data analysis; and the information matching and intelligent recommendation module is used for performing data matching and mining on the information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database, and acquiring a data result corresponding to the information to be evaluated.
3. The system of claim 1, wherein the system comprises: the interactive terminal comprises an information receiving and uploading module and a result display module; the information receiving and uploading module is used for receiving and uploading information to be evaluated, which is input by a user at the interactive terminal; the result display module; and the data processing module is used for returning the data result corresponding to the information to be evaluated to the interactive terminal for displaying.
4. The system of claim 1, wherein the system comprises: the system for evaluating the risk of the multiple medication of the old patients further comprises a multiple medication risk database establishing module which is used for establishing the multiple medication risk database according to the medicine and disease information.
5. The system of claim 4, wherein the risk assessment system for multiple medication of the elderly patient comprises: the medicine and disease information comprises medicine names, disease names, clinical index early warning values and medicine and disease interaction information.
6. The system of claim 5, wherein the risk assessment system for multiple medication of the elderly patient comprises: the drug disease interaction information includes disease-drug risk, potentially inappropriate administration for geriatric syndrome, potentially inappropriate administration risk for the elderly, perioperative administration risk, pre-alarm value risk drugs;
wherein the disease-drug risk information is medication risk points and use suggestions for using a certain drug in a known geriatric disease state; potentially inappropriate medication for geriatric syndrome information is inappropriate medication in the context of known geriatric syndrome; the potential improper medication risk information of the old people is medication risk points/use suggestions corresponding to some medicines which may not be suitable for the old people, and two levels are adopted to warn the classification of the medicines and the risk intensity of the medicines; the perioperative medication risk information is the potential risk and use suggestion corresponding to the improper medication of the elderly patients in the period from the determination of the start of the operation treatment to the end of the operation treatment; the early warning value risk medicine information is risk medicine of the old in a certain physiological index range.
7. The system of claim 1, wherein the system comprises: the information to be evaluated comprises medicine-disease names, senile syndrome names, potentially improper medication names of the elderly, perioperative risk medicine names and clinical index early warning values.
8. A method for evaluating the risk of multiple medication of an elderly patient, which utilizes the system for evaluating the risk of multiple medication of an elderly patient according to any one of claims 1-7 to evaluate the risk of multiple medication of an elderly patient, comprising the following steps:
s101: establishing a multi-medication risk database
Establishing and storing a multiple medication risk database according to the medicine and disease information;
s102: receiving and uploading information
Receiving and uploading information to be evaluated input by a user at an interactive terminal;
s103: information matching and intelligent recommendation
Performing data matching and mining on information to be evaluated from the interactive terminal according to the medicine and disease information in the multi-medication risk database, and obtaining a data result corresponding to the information to be evaluated;
s104: show the results
Returning a data result corresponding to the information to be evaluated to the interactive terminal for displaying;
s105: recording usage information
And recording the use information of the user at the interactive terminal for subsequent analysis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010364749.XA CN111564195A (en) | 2020-04-30 | 2020-04-30 | System and method for evaluating risk of multiple medication of old patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010364749.XA CN111564195A (en) | 2020-04-30 | 2020-04-30 | System and method for evaluating risk of multiple medication of old patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111564195A true CN111564195A (en) | 2020-08-21 |
Family
ID=72071709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010364749.XA Pending CN111564195A (en) | 2020-04-30 | 2020-04-30 | System and method for evaluating risk of multiple medication of old patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111564195A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112270967A (en) * | 2020-11-16 | 2021-01-26 | 上海陶术生物科技有限公司 | Drug disease matching database |
| CN112561601A (en) * | 2020-12-24 | 2021-03-26 | 辽宁师范大学 | Information service online promotion system and method based on old health |
| CN112786213A (en) * | 2020-12-26 | 2021-05-11 | 四川大学华西医院 | System and method for comprehensively evaluating multiple medication risks |
| CN113643783A (en) * | 2021-08-13 | 2021-11-12 | 今彩慧健康科技(苏州)有限公司 | Sub-health population drug recommendation method, system, equipment and storage medium |
| CN114678140A (en) * | 2020-12-24 | 2022-06-28 | 宏碁股份有限公司 | Calculation method of high-risk medication path |
| CN116884566A (en) * | 2023-07-14 | 2023-10-13 | 盐城市食品药品监督检验中心 | Medication risk monitoring and evaluating method and system |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103649959A (en) * | 2011-03-10 | 2014-03-19 | 梯瓦制药工业有限公司 | A method, system and program for improved health care |
| CN106126935A (en) * | 2016-06-24 | 2016-11-16 | 北京千安哲信息技术有限公司 | A kind of safe medication monitoring system and monitoring method thereof |
| CN106250696A (en) * | 2016-08-03 | 2016-12-21 | 董碧蓉 | Old people's rational use of drug assessment system and method |
| CN106295130A (en) * | 2016-07-27 | 2017-01-04 | 珠海亿联德源信息技术有限公司 | Old comprehensive assessment all-in-one |
| CN110136838A (en) * | 2019-04-29 | 2019-08-16 | 平安科技（深圳）有限公司 | Data Matching decision-making technique and system based on multiple knowledge base reasoning |
| US20200013515A1 (en) * | 2018-07-03 | 2020-01-09 | Talis Clinical LLC | Drug interaction checking tool |
-
2020
- 2020-04-30 CN CN202010364749.XA patent/CN111564195A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103649959A (en) * | 2011-03-10 | 2014-03-19 | 梯瓦制药工业有限公司 | A method, system and program for improved health care |
| CN106126935A (en) * | 2016-06-24 | 2016-11-16 | 北京千安哲信息技术有限公司 | A kind of safe medication monitoring system and monitoring method thereof |
| CN106295130A (en) * | 2016-07-27 | 2017-01-04 | 珠海亿联德源信息技术有限公司 | Old comprehensive assessment all-in-one |
| CN106250696A (en) * | 2016-08-03 | 2016-12-21 | 董碧蓉 | Old people's rational use of drug assessment system and method |
| US20200013515A1 (en) * | 2018-07-03 | 2020-01-09 | Talis Clinical LLC | Drug interaction checking tool |
| CN110136838A (en) * | 2019-04-29 | 2019-08-16 | 平安科技（深圳）有限公司 | Data Matching decision-making technique and system based on multiple knowledge base reasoning |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112270967A (en) * | 2020-11-16 | 2021-01-26 | 上海陶术生物科技有限公司 | Drug disease matching database |
| CN112561601A (en) * | 2020-12-24 | 2021-03-26 | 辽宁师范大学 | Information service online promotion system and method based on old health |
| CN114678140A (en) * | 2020-12-24 | 2022-06-28 | 宏碁股份有限公司 | Calculation method of high-risk medication path |
| CN112561601B (en) * | 2020-12-24 | 2024-04-05 | 辽宁师范大学 | Online information service popularization system and method based on old people health |
| CN112786213A (en) * | 2020-12-26 | 2021-05-11 | 四川大学华西医院 | System and method for comprehensively evaluating multiple medication risks |
| CN112786213B (en) * | 2020-12-26 | 2023-03-10 | 四川大学华西医院 | System and method for comprehensively evaluating multiple medication risks |
| CN113643783A (en) * | 2021-08-13 | 2021-11-12 | 今彩慧健康科技(苏州)有限公司 | Sub-health population drug recommendation method, system, equipment and storage medium |
| CN116884566A (en) * | 2023-07-14 | 2023-10-13 | 盐城市食品药品监督检验中心 | Medication risk monitoring and evaluating method and system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111564195A (en) | System and method for evaluating risk of multiple medication of old patients | |
| Janjua et al. | Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD) | |
| Miller et al. | Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews | |
| Galasko et al. | Clinical-neuropathological correlations in Alzheimer's disease and related dementias | |
| Rattehalli et al. | Risperidone versus placebo for schizophrenia | |
| Fuchs-Lacelle et al. | Pain assessment as intervention: a study of older adults with severe dementia | |
| Miller | Inpatient diagnostic assessments: 2. Interrater reliability and outcomes of structured vs. unstructured interviews | |
| Guénette et al. | Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records | |
| Clark et al. | Patient factors and compliance with asthma therapy | |
| US20030092976A1 (en) | Interactive medical diagnostic device | |
| EP1946235A1 (en) | Clinical workflow management and decision system and method | |
| CN112133397A (en) | Dynamic management method and device for patient medicine taking and storage medium | |
| Sbarbaro | Strategies to improve compliance with therapy | |
| Semla et al. | Drug use patterns of persons with Alzheimer's disease and related disorders living in the community | |
| CN110459311A (en) | The medication alert system and method remotely monitored for patient's medication | |
| CN111584095A (en) | Auxiliary support system for participating in treatment decision of primary liver cancer patient | |
| JP2002015061A (en) | Clinical test performance management system | |
| CN117558464A (en) | Method for constructing ADR prediction model of elderly patient, prediction system and storage medium | |
| Stanley et al. | Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients | |
| CN112786213B (en) | System and method for comprehensively evaluating multiple medication risks | |
| JP2006185396A (en) | Diagnostic treatment support system with biological rhythm taken into consideration | |
| Wilkie et al. | High dose neuroleptics–who gives them and why? | |
| Chaney et al. | Differential effects of age and illness duration on pain-depression and disability-depression relationships in rheumatoid arthritis | |
| CN108231205B (en) | Inpatient medication information color chart analysis system and method | |
| US20030181792A1 (en) | Healthcare outcome measurement, analysis and improvement system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200821 |